相似文献
1
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.
Cancer Cell. 2007 Aug;12(2):108-13. doi: 10.1016/j.ccr.2007.07.006.
2
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Cell Oncol (Dordr). 2021 Oct;44(5):1151-1166. doi: 10.1007/s13402-021-00625-w. Epub 2021 Aug 2.
3
Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
Cell Death Differ. 2008 Apr;15(4):672-7. doi: 10.1038/sj.cdd.4402302. Epub 2008 Jan 11.
4
Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.
Cell Cycle. 2007 Aug 1;6(15):1919-26. doi: 10.4161/cc.6.15.4515. Epub 2007 May 27.
5
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
Cancer Cell. 2007 Apr;11(4):335-47. doi: 10.1016/j.ccr.2007.02.006.
6
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma.
Cancer Sci. 2021 Oct;112(10):3995-4004. doi: 10.1111/cas.15087. Epub 2021 Aug 9.
7
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
Oncotarget. 2016 Dec 13;7(50):82658-82670. doi: 10.18632/oncotarget.12308.
8
c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
Oncotarget. 2016 Nov 29;7(48):78910-78917. doi: 10.18632/oncotarget.12911.
9
Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
Leuk Lymphoma. 2015 Jun;56(6):1821-30. doi: 10.3109/10428194.2014.963575. Epub 2014 Oct 21.
10
Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols.
Toxicol Appl Pharmacol. 2012 Mar 1;259(2):210-8. doi: 10.1016/j.taap.2011.12.025. Epub 2012 Jan 5.
引用本文的文献
1
FBXO22 regulates proliferation, migration, and invasion of esophageal cancer cells via the WNT/β-catenin signaling pathway.
Am J Transl Res. 2025 Aug 15;17(8):5962-5974. doi: 10.62347/TOAI4814. eCollection 2025.
2
Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent.
Int J Mol Sci. 2025 Aug 19;26(16):8003. doi: 10.3390/ijms26168003.
3
Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications.
Cell Death Discov. 2025 Aug 25;11(1):405. doi: 10.1038/s41420-025-02696-2.
4
A lactate related signature for predicting prognosis and tumor microenvironment in lung adenocarcinoma.
Discov Oncol. 2025 Jul 1;16(1):1206. doi: 10.1007/s12672-025-03015-y.
5
Identification and validation of hypoxia-associated genes positively correlated with in pulmonary adenocarcinoma.
Transl Cancer Res. 2025 May 30;14(5):3113-3132. doi: 10.21037/tcr-2024-2265. Epub 2025 May 27.
6
Antigen-specific CD4+ T cells promote monocyte recruitment and differentiation into glycolytic lung macrophages to control Mycobacterium tuberculosis.
PLoS Pathog. 2025 Jun 9;21(6):e1013208. doi: 10.1371/journal.ppat.1013208. eCollection 2025 Jun.
7
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma.
Neoplasia. 2025 Aug;66:101188. doi: 10.1016/j.neo.2025.101188. Epub 2025 Jun 4.
8
Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker.
Int J Mol Sci. 2025 Mar 21;26(7):2848. doi: 10.3390/ijms26072848.
9
Antitumor effects of dauricine on sorafenib-treated human lung cancer cell lines via modulation of HIF-1α signaling pathways.
Med Oncol. 2025 Apr 10;42(5):157. doi: 10.1007/s12032-025-02679-4.
10
HIF-1 regulates mitochondrial function in bone marrow-derived macrophages but not in tissue-resident alveolar macrophages.
Sci Rep. 2025 Apr 4;15(1):11574. doi: 10.1038/s41598-025-95962-3.
本文引用的文献
1
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
Cancer Cell. 2007 May;11(5):407-20. doi: 10.1016/j.ccr.2007.04.001.
2
The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis.
Genes Dev. 2007 May 1;21(9):1037-49. doi: 10.1101/gad.1529107. Epub 2007 Apr 16.
3
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells.
Cell. 2007 Apr 6;129(1):111-22. doi: 10.1016/j.cell.2007.01.047.
4
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
Cancer Cell. 2007 Apr;11(4):335-47. doi: 10.1016/j.ccr.2007.02.006.
5
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting.
Cancer Res. 2007 Feb 1;67(3):854-5. doi: 10.1158/0008-5472.CAN-06-4744.
6
Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.
Cancer Cell. 2006 Nov;10(5):413-23. doi: 10.1016/j.ccr.2006.08.026.
7
The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression.
EMBO J. 2006 Oct 18;25(20):4784-94. doi: 10.1038/sj.emboj.7601369. Epub 2006 Oct 5.
8
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Nature. 2006 Aug 17;442(7104):779-85. doi: 10.1038/nature05029.
9
How do cancer cells acquire the fuel needed to support cell growth?
Cold Spring Harb Symp Quant Biol. 2005;70:357-62. doi: 10.1101/sqb.2005.70.011.
10
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.
Cancer Cell. 2006 Jun;9(6):425-34. doi: 10.1016/j.ccr.2006.04.023.
Zotero 插件